The IUCN Global Standard for Nature-based Solutions™ as a tool for enhancing the sustainable development of marine aquaculture

This paper applies the IUCN Global Standard for Nature based Solutions™ self-assessment tool (published in 2020) to two aquaculture case studies. Data from the case studies were compiled by the authors. In Zanzibar, secondary data were obtained through a previous project, which included a stakeholder workshop in Zanzibar (in 2019) and one deliverable published by the IUCN on Zanzibar of their catalogue “Aquaculture and Marine Conservation”. In Indonesia, the original data were provided by the Blue Natural Capital Funding Facility (BNCFF) and the associated local teams. The analysis of the data, the information provided, and the scoring itself were done by the authors, in association with local teams in both areas. The results of the two assessments, discussed in the paper and presented in detail in the Supplementary materials, can be considered original research, never previously published in a scientific journal. The concept of Nature-based Solutions (NbS) was proposed by the International Union for Conservation of Nature (IUCN) to protect, restore, and sustainably manage natural and modified ecosystems for achieving a variety of societal benefits. The IUCN released the IUCN Global Standard for NbS™ to help design, assess, strengthen, and upscale NbS interventions. In the current context of growing uncertainties for the future of coastlines and oceans, aquaculture has been recognized as a positive activity for achieving sustainable development in coastal communities; supporting food security, poverty alleviation, and economic resilience; and contributing to the conservation of marine ecosystems in some cases. However, the sustainability of aquaculture systems has often been criticized. Aquaculture initiatives in coastal areas can achieve both nature conservation and sustainable development objectives, but reflection on the conditions under which this would happen is needed. This article examines aquaculture systems through the lens of the NbS concept and the IUCN Global Standard for NbS™, along with other sustainability concepts and instruments currently used in the context of aquaculture. The application of the IUCN Global Standard for NbS™’s to two case studies is explored: seaweed farming in Zanzibar in marine conservation areas and shrimp farming coupled with mangrove restoration in Indonesia. The results show that the NbS concept underpinning the IUCN Global Standard for NbS™ could help in the overall assessment of aquaculture systems and improve their sustainability by highlighting both their positive outcomes and issues requiring further examination in relation to marine biodiversity benefits, socio-economic development, and/or governance. The IUCN Global Standard for NbS™ could provide an operational framework to implement existing concepts, such as the Ecosystem Approach to Aquaculture, contribute to clarifying critical issues in aquaculture development, and provide guidance for the development of a new type of aquaculture project, specifically designed as NbS. This finding advocates the context-dependent exploration and promotion of aquaculture projects as NbS

Les Sadducéens et l'origine des partis juifs de la période du Second Temple

PARIS-EPHE-Sciences religieuses (751052336) / SudocSudocFranceF

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade

Abstract Background Inducible T cell costimulator ICOS is an emerging target in immuno-oncology. The aim of this study was to investigate the epigenetic regulation of ICOS in melanoma by DNA methylation. Methods We comprehensively investigate ICOS DNA methylation of specific CpG sites and expression pattern within the melanoma microenvironment with regard to immune correlates, differentiation, clinical outcomes, and immune checkpoint blockade (ICB) response. Results Our study revealed a sequence-contextual CpG methylation pattern consistent with an epigenetically regulated gene. We found a cell type-specific methylation pattern and locus-specific correlations and associations of CpG methylation with ICOS mRNA expression, immune infiltration, melanoma differentiation, prognosis, and response to ICB. High ICOS mRNA expression was identified as a surrogate for enriched immune cell infiltration and was associated with favorable overall survival (OS) in non-ICB-treated patients and predicted response and a prolonged progression-free survival (PFS) following ICB therapy initiation. ICOS hypomethylation, however, significantly correlated with poor OS in non-ICB patients but predicted higher response and prolonged PFS and OS in ICB-treated patients. Moreover, we observed cytoplasmic and sporadically nuclear tumor cell-intrinsic ICOS protein expression. Tumor cell-intrinsic ICOS protein and mRNA expression was inducible by pharmacological demethylation with decitabine. Conclusion Our study identified ICOS DNA methylation and mRNA expression as promising prognostic and predictive biomarkers for immunotherapy in melanoma and points towards a hitherto undescribed role of ICOS in tumor cells

Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19

Importance: Research diversity and representativeness are paramount in building trust, generating valid biomedical knowledge, and possibly in implementing clinical guidelines. Objectives: To compare variations over time and across World Health Organization (WHO) geographic regions of corticosteroid use for treatment of severe COVID-19; secondary objectives were to evaluate the association between the timing of publication of the RECOVERY (Randomised Evaluation of COVID-19 Therapy) trial (June 2020) and the WHO guidelines for corticosteroids (September 2020) and the temporal trends observed in corticosteroid use by region and to describe the geographic distribution of the recruitment in clinical trials that informed the WHO recommendation. Design, setting, and participants: This prospective cohort study of 434 851 patients was conducted between January 31, 2020, and September 2, 2022, in 63 countries worldwide. The data were collected under the auspices of the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC)-WHO Clinical Characterisation Protocol for Severe Emerging Infections. Analyses were restricted to patients hospitalized for severe COVID-19 (a subset of the ISARIC data set). Exposure: Corticosteroid use as reported to the ISARIC-WHO Clinical Characterisation Protocol for Severe Emerging Infections. Main outcomes and measures: Number and percentage of patients hospitalized with severe COVID-19 who received corticosteroids by time period and by WHO geographic region. Results: Among 434 851 patients with confirmed severe or critical COVID-19 for whom receipt of corticosteroids could be ascertained (median [IQR] age, 61.0 [48.0-74.0] years; 53.0% male), 174 307 (40.1%) received corticosteroids during the study period. Of the participants in clinical trials that informed the guideline, 91.6% were recruited from the United Kingdom. In all regions, corticosteroid use for severe COVID-19 increased, but this increase corresponded to the timing of the RECOVERY trial (time-interruption coefficient 1.0 [95% CI, 0.9-1.2]) and WHO guideline (time-interruption coefficient 1.9 [95% CI, 1.7-2.0]) publications only in Europe. At the end of the study period, corticosteroid use for treatment of severe COVID-19 was highest in the Americas (5421 of 6095 [88.9%]; 95% CI, 87.7-90.2) and lowest in Africa (31 588 of 185 191 [17.1%]; 95% CI, 16.8-17.3). Conclusions and relevance: The results of this cohort study showed that implementation of the guidelines for use of corticosteroids in the treatment of severe COVID-19 varied geographically. Uptake of corticosteroid treatment was lower in regions with limited clinical trial involvement. Improving research diversity and representativeness may facilitate timely knowledge uptake and guideline implementation

The value of open-source clinical science in pandemic response: lessons from ISARIC

International audienc